Children's Hospital of Philadelphia
chop.eduLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
482
Active
102
Phase 3
21
Total enrollment
3,013,773
Pipeline matrix
Showing 24 of 24 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Contrast-Enhanced Ultrasound using Lumason | — | — | — | — | — | 1 | |
| Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON] | — | — | — | — | — | 1 | |
| CART19 | — | — | — | — | — | 1 | |
| alpelisib | — | — | — | — | — | 1 | |
| Trametinib | — | — | — | — | — | 1 | |
| Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON] | — | — | — | — | — | 1 | |
| Red cell units that are genotype matched at the RHD and RHCE loci | — | — | — | — | — | 1 | |
| ALS20 | — | — | — | — | — | 1 | |
| Lurbinectedin | — | — | — | — | — | 1 | |
| RIC: Distal Campath | — | — | — | — | — | 1 | |
| RIC:Intermediate Campath | — | — | — | — | — | 1 | |
| RIC: Mini Busulfan | — | — | — | — | — | 1 | |
| Rifampin | — | — | — | — | — | 1 | |
| Selpercatinib Monotherapy | — | — | — | — | — | 1 | |
| Larotrectinib monotherapy | — | — | — | — | — | 1 | |
| Lumason® contrast agent | — | — | — | — | — | 1 | |
| Ferumoxytol | — | — | — | — | — | 1 | |
| Cabozantinib | — | — | — | — | — | 1 | |
| Transplant of stem cells with CD3+/CD19+ depletion | — | — | — | — | — | 1 | |
| 18F-Fluciclovine PET-MRI | — | — | — | — | — | 1 | |
| Lumason | — | — | — | — | — | 1 | |
| BK-virus specific CTLs | — | — | — | — | — | 1 | |
| 18F-Fluciclovine | — | — | — | — | — | 1 | |
| Blood or Saliva Sample Collection | — | — | — | — | — | 1 |
Next readouts
- 2024-07
- 2026-07
- 2026-09
- 2026-10-01
- 2026-12
- 2026-12
- 2026-12
- 2026-12-31
- 2027-01
- 2027-04
Top conditions
- Cystic Fibrosis13
- Asthma9
- Depression9
- Cancer8
- Leukemia7
- Obesity7
- Parent-Child Relations7
- Cardiac Arrest7
Frequently asked questions about Children's Hospital of Philadelphia
- How many clinical trials does Children's Hospital of Philadelphia have on ClinicalTrials.gov?
- Children's Hospital of Philadelphia is listed as the lead sponsor on 482 clinical trials in ClinicalTrials.gov, 102 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Children's Hospital of Philadelphia's trials are in Phase 3?
- 21 of Children's Hospital of Philadelphia's trials are in Phase 3, spread across 24 active drug programs.
- What therapeutic areas does Children's Hospital of Philadelphia focus on?
- Children's Hospital of Philadelphia's most-studied conditions on ClinicalTrials.gov are Cystic Fibrosis, Asthma, Depression, Cancer, Leukemia.
- When are Children's Hospital of Philadelphia's next clinical trial readouts?
- Children's Hospital of Philadelphia has 10 upcoming primary-completion readouts tracked here; the soonest is “Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders”, expected around 2024-07.